Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vu Long Tran

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Materials Chemistry. B|April 8, 2020
One-pot direct synthesis for multifunctional ultrasmall hybrid silica nanoparticlesVu-Long Tran, Vivek Thakare, Fabien Rossetti, et al.
Theranostics|October 14, 2020
A snake toxin as a theranostic agent for the type 2 vasopressin receptorLaura Droctové, Manon Lancien, Vu Long Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanomaElena Garralda, Christoph Markert, Victor Moreno, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumorsKristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
The British Journal of Radiology|September 19, 2018
AGuIXFrançois Lux, Vu Long Tran, Eloïse Thomas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Materials Chemistry. B|April 8, 2020
One-pot direct synthesis for multifunctional ultrasmall hybrid silica nanoparticlesVu-Long Tran, Vivek Thakare, Fabien Rossetti, et al.
Theranostics|October 14, 2020
A snake toxin as a theranostic agent for the type 2 vasopressin receptorLaura Droctové, Manon Lancien, Vu Long Tran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2026
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanomaElena Garralda, Christoph Markert, Victor Moreno, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
First-in-human study of lomvastomig, a PD-1-TIM-3 bispecific antibody, in patients with advanced and/or metastatic solid tumorsKristoffer Staal Rohrberg, Ignacio Melero, Miguel F Sanmamed, et al.
The British Journal of Radiology|September 19, 2018
AGuIXFrançois Lux, Vu Long Tran, Eloïse Thomas, et al.
Pageof 2